Source: Annual Congress 2008 - Why vaccinate patients with chronic respiratory conditions? Today and tomorrow's perspectives
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
P. Blank (Zurich, Switzerland). Societal perspective and challenges of influenza and pneumococcal vaccination in patients at risk of respiratory complications. Annual Congress 2008 - Why vaccinate patients with chronic respiratory conditions? Today and tomorrow's perspectives

Member's Comments

No comment yet.

Related content which might interest you: Vaccination rates against pneumococcal and influenza infection in hospitalized cardiologic and pneumologic patients need to be improved. Source: International Congress 2018 – Respiratory epidemiology:  from infectious diseases to lung cancer Year: 2018 Factors affecting attitude towards pneumococcal and influenza vaccination in patients admitting to a pulmonary diseases outpatient clinic Source: Annual Congress 2012 - Effectiveness of therapeutic interventions in primary care Year: 2012 Additive preventive effect of influenza and pneumococcal vaccines in elderly persons Source: Eur Respir J 2004; 23: 363-368 Year: 2004 Perception and uptake of the influenza and pneumococcal vaccinations in patients with COPD Source: Annual Congress 2008 - Organisation of care and management of COPD Year: 2008 Influenza and pneumococcal vaccination in patients with COPD Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Efficacy of influenza and pneumococcal vaccinations among patients with COPD Source: Annual Congress 2007 - Treatment of COPD Year: 2007 The importance of pneumococcal and influenza vaccines in patients with allergic asthma Source: Eur Respir J 2005; 26: Suppl. 49, 376s Year: 2005 Should pneumococcal vaccines be used to prevent LRTI? Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new? Year: 2009 The remaining challenges of pneumococcal disease in adults Source: Eur Respir Rev 2012; 21: 57-65 Year: 2012 Protective effect of pneumococcal vaccine against death by pneumonia in elderly subjects Source: Eur Respir J 2005; 26: 1086-1091 Year: 2005 Risk factors for respiratory failure in pneumococcal pneumonia: the importance of pneumococcal serotypes Source: Eur Respir J 2014; 43: 545-553 Year: 2013 Efficiency and safety of influenza vaccines in children with chronic diseases and deviations in state of health Source: Eur Respir J 2007; 30: Suppl. 51, 622s Year: 2007 Influenza and pneumoccocal vaccination protect against all cause mortality in COPD Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention Year: 2008 Effectiveness of a protocolized care intervention for adults with pneumonia associated with pandemic H1N1 virus Source: Annual Congress 2010 - Risk factors and outcomes in community-acquired pneumonia Year: 2010 Vaccinating children against influenza: a systematic review of the evidence for community protection Source: Annual Congress 2005 - Host-pathogen interaction in respiratory virus infections Year: 2005 Australian perceptions of pertussis and vaccine preventable disease in the setting of asthma and COPD Source: International Congress 2019 – Airway infection in COPD Year: 2019 Effects of pneumococcal vaccine in patients with chronic respiratory disease Source: Eur Respir Rev 2008; 17: 43-45 Year: 2008